Ditiocarb sodium
CAS No. 148-18-5
Ditiocarb sodium ( Sodium diethyldithiocarbamate )
Catalog No. M20541 CAS No. 148-18-5
Ditiocarb sodium (Sodium diethyldithiocarbamate) is an accelerator of the rate of copper cementation. Sodium diethyldithiocarbamate reduces the incidence of HIV infection.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
500MG | 37 | In Stock |
|
1G | 43 | In Stock |
|
Biological Information
-
Product NameDitiocarb sodium
-
NoteResearch use only not for human use.
-
Brief DescriptionDitiocarb sodium (Sodium diethyldithiocarbamate) is an accelerator of the rate of copper cementation. Sodium diethyldithiocarbamate reduces the incidence of HIV infection.
-
DescriptionDitiocarb sodium (Sodium diethyldithiocarbamate) is an accelerator of the rate of copper cementation. Sodium diethyldithiocarbamate reduces the incidence of HIV infection.
-
SynonymsSodium diethyldithiocarbamate
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number148-18-5
-
Formula Weight171.26
-
Molecular FormulaC5H10NNaS2
-
Purity>98% (HPLC)
-
SolubilityDMSO:300 mg/mL (1751.72 mM)
-
SMILES[Na+].CCN(CC)C([S-])=S
-
Chemical NameCarbamodithioic acid diethyl- sodium salt
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.El-Saharty A A El-Hammamy N H El-Araby H A . Sodium diethyldithiocarbamate as accelerator of the rate of copper cementation[J]. The Egyptian Journal of Aquatic Research 2015 41(4):289-293.
molnova catalog
related products
-
BMS-707035
BMS-707035 is a potent, specific, and reversible HIV-I integrase (IN) inhibitor that blocks HIV IN strand transfer activity with IC50 of 15 nM.
-
NBD-557
A potent HIV-1 entry inhibitor that blocks the gp120-CD4 interaction; inhibits the fusion between HIV-1NL4-3-luc pseudotyped virus expressing HIV-1HXB2 (X4-tropic) envelope and U87-T4-CXCR4 cells with IC50 of 9.7 uM.
-
NBD-556
A potent HIV-1 entry inhibitor that blocks the gp120-CD4 interaction.